LEIGH SCHARFF: Open Payments
NPI 1962756072 · IOLA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$379 in 27 payments from 7 companies in 2025. Trend: 2023 $411 · 2024 $401 · 2025 $379
Food & beverage: $379
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $137 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $109 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $33 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Viatris Specialty LLC | 1 | $15 |
Products named: VRAYLAR, CAPLYTA, FARXIGA, JOURNAVX, GEMTESA, Auvelity, YUPELRI.
Industry payments across KS — which companies pay providers there.
